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As part of the International Multi-centre ADHD Genetics project we completed an affected
sibling pair study of 142 narrowly defined Diagnostic and Statistical Manual of Mental
Disorders, fourth edition combined type attention deficit hyperactivity disorder (ADHD)
proband–sibling pairs. No linkage was observed on the most established ADHD-linked
genomic regions of 5p and 17p. We found suggestive linkage signals on chromosomes 9 and
16, respectively, with the highest multipoint nonparametric linkage signal on chromosome
16q23 at 99 cM (log of the odds, LOD = 3.1) overlapping data published from the previous
UCLA (University of California, Los Angeles) (LOD > 1, B95 cM) and Dutch (LOD > 1, B100 cM)
studies. The second highest peak in this study was on chromosome 9q22 at 90 cM (LOD = 2.13);
both the previous UCLA and German studies also found some evidence of linkage at almost
the same location (UCLA LOD = 1.45 at 93 cM; German LOD = 0.68 at 100 cM). The overlap of
these two main peaks with previous findings suggests that loci linked to ADHD may lie within
these regions. Meta-analysis or reanalysis of the raw data of all the available ADHD linkage
scan data may help to clarify whether these represent true linked loci.
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Introduction
Attention deficit hyperactivity disorder (ADHD) is
one of the most common behavioral disorders of
childhood, characterized by the early onset of age
inappropriate hyperactivity, impulsivity and inatten-
tiveness. Family studies indicate a sibling relative
risk (ls) around 4–6.1–3 A recent review of 20
population twin studies from around the world found
an average heritability of 76%, suggesting that genetic
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influences play a major role in the etiology of ADHD.4
Candidate gene studies have so far confirmed associa-
tions to genetic variants within or close to the
dopamine D4 and D5 receptor genes5 and identified
variants in several other genes that appear to increase
the risk of ADHD.4 The genetic variants identified so
far contribute only a small amount to the phenotypic
variance explained by genetic factors and the
expectation is that further genes will be found that
are associated with the disorder.6
A major strategy in the search for novel genes that
increase the risk for ADHD and other complex
disorders is the use of genome-wide linkage scans to
identify chromosomal regions containing susceptibi-
lity loci. To date five independent ADHD genome-
wide linkage studies have been completed. Four of
them adopted the affected sib pair strategy with
samples from University of California, Los Angeles
(UCLA),7,8 MGH,9 the Netherlands10 and Germany.11
The fifth used extended pedigrees ascertained from a
population isolate in Columbia.12 With the exception
of the MGH scan, each study identified novel genomic
regions that might harbor ADHD-associated genes.
The most significant findings reported on chromo-
somes 5p and 17p where linkage signals were found
in multiple studies.8,11,12 Although as yet no genes
explaining any of the linkage findings have been
reported in the published literature, one study
suggested that genetic variation of the dopamine
transporter gene (DAT1) might explain linkage on
chromosome 5p.13
In the current study we contribute to linkage
findings from affected sibling pair studies of ADHD,
using a sample of 142 Diagnostic and Statistical
Manual of Mental Disorders, fourth edition (DSM-IV)
combined subtype ADHD proband–sibling pairs,
ascertained by the International Multi-centre ADHD
Genetics (IMAGE) project.1,6 Using a panel of highly
informative single nucleotide polymorphisms (SNPs)
our main aim was to identify genetic linkage regions
using a sample ascertained with a relatively homo-
geneous phenotype. In light of the background genetic
heterogeneity observed within our multi-country
sample at 51 ADHD candidate genes,14 we also
performed simulations to investigate the potential
impact of locus-specific genetic heterogeneity on the
linkage signals observed in this study.
Materials and methods
Sample ascertainment and diagnosis
Families were identified by the IMAGE consortium
through clinically diagnosed combined subtype
ADHD cases at specialist clinics in eight European
countries: Belgium, England, Germany, Ireland, Israel,
the Netherlands, Spain and Switzerland. To ensure
the genetic homogeneity of the sample only white
Caucasians of European ancestry were included based
on information on ethnicity going back to grand-
parents of the affected sibling pairs. Entry criteria for
research assessments were (1) a proband with the
ADHD combined subtype, (2) availability of one or
more siblings of each affected proband and (3) both
the probands and siblings aged between 5 and 17 at
the time of assessment,14 both the children and at
least one of their biological parents were available for
DNA collection. Eligible families were then invited to
the research centers or assessed during home assess-
ments by qualified child psychiatrists or trained
interviewers using clinical research assessments.
Blood or buccal samples were collected for DNA
extraction. Exclusion criteria applied to both
probands and siblings: (1) IQ < 70, (2) a diagnosis of
schizophrenia or autism that might confound the
diagnosis of ADHD and (3) neurological disorders
such as epilepsy and brain injury, as well as
any genetic or medical disorder associated with
externalizing behaviors that might mimic ADHD.
Clinical procedures
Parental account of childhood symptom. Parental
account of childhood symptom (PACS) is a
semi-structured, standardized, investigator-based
interview developed as an instrument to provide an
objective measure of child behavior.15–17 A trained
interviewer administers PACS with parents, who are
asked for detailed descriptions of the child’s typical
behavior in a range of specified situations. Such
situations either by external events (for example,
watching television, reading a book or comic, playing
alone, playing with friends, going to bed, traveling) or
by behaviors are shown (for example, crying, worried
talk, tempers, fighting with siblings). Interviewers
then make their own ratings on the basis of a formal
training and written definitions of the behaviors to be
rated, on a four-point scale of severity and frequency
in the previous week and previous year. The
Hyperactivity subscale is made up of attention span
(time spent on a single activity, rated separately for
four different kinds of activity), restlessness (moving
about during the same activities), fidgetiness
(movements of parts of the body during the same
activities) and activity level (rated for structured
situations such as mealtimes and car journeys), with
other subscales covering defiant, emotional and other
comorbid disorders including autistic spectrum
disorders.
Inter-rater reliability is high with previous esti-
mates of product–moment correlations for pairs of
interviewers ranging from 0.92 to 0.95 for ‘hyperacti-
vity’, 0.89 to 0.95 for ‘defiance’ and 0.79 to 0.90 for
‘emotional problems’.17 The internal consistency of
the scales for behavior was acceptably good:
Cronbach’s a was 0.89 for ‘hyperactivity’ and 0.87
for ‘defiance’.15 For this study, all interviewers from
each site attended a 5-day PACS training course in the
United Kingdom. Each site further nominated a
chief investigator who attended annual inter-rater
reliability exercises. For sites with more than one
interviewer, the chief investigator undertook further
inter-rater reliability checks regularly. A mean
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k coefficient across all the sites of 0.88 (range 0.71–
1.00) and an average agreement percentage of 96.6%
(range 78.6–100) were obtained, indicating a high
level of inter-rater agreement. Concurrent validity of
PACS diagnosis is confirmed by the bi-serial correla-
tion between PACS diagnosis of combined type
ADHD with Conners’ teacher N-scale scores (the 18
DSM items for ADHD) of 0.68 and Conners’ parent N-
scale scores at 0.78.
Rating scales. Rating scales used to quantify ADHD
symptoms included the Long Version of Conners’
Parent Rating Scale, the Long Version of Conners’
Teacher Rating Scale (CTRS-R:L) and parent and
teacher versions of the Strengths and Difficulties
Questionnaires (SDQ).18,19 In the analyses presented
here only ADHD symptoms derived from the CTRS-
R:L were included as part of the diagnostic algorithm
for ADHD with parent data derived from the PACS
interview (see below). To exclude autism spectrum
disorders that might confound the analysis of ADHD,
both probands and siblings were screened using
the Social Communication Questionnaire (SCQ) in
conjunction with the prosocial scale from the SDQ.
Individuals falling above thresholds for the SCQ
(X15) and SDQ (p4) were further evaluated using
the autism spectrum disorder section of the PACS
interview. A diagnosis of possible autism or autism
spectrum disorder led to exclusion from the study.
DSM-IV diagnoses. All raw data were centralized
and stored on a secure database at the MRC Social
Genetic Developmental Psychiatry research center in
London. A standardized algorithm was applied to
PACS to derive each of the 18 DSM-IV ADHD items,
providing operational definitions for each behavioral
symptom. These were combined with items that
scored 2 or 3 from the teacher rated Conners’ ADHD
subscale, to generate the total number of items
from the DSM-IV symptom checklist. Situational
pervasiveness was defined as some symptoms
occurring within two or more different situations
from the PACS interview plus the presence of one or
more symptoms scoring 2 or more from the ADHD
subscale of the Conners’ teacher ratings. In a few
cases where teacher Conners data were unavailable,
pervasiveness was defined on the basis of PACS data
alone.
Sample selection. After pedigree correction using
the linkage markers to check for expected family
relationships, the final sample in this study consisted
of 577 subjects, including 276 ADHD combined
subtype cases from 134 nuclear families. With eight
families having three affected children, a total of 142
independent sibling pairs with combined subtype
ADHD were formed. Table 1 summarizes the clinical
characteristics of the sample according to the
ascertainment procedure, alongside those from
previously published affected sibling pair studies
of ADHD. Genotypes were available to maximize
identity-by-descent information from both parents in
111 families and from one parent plus an additional
unaffected sibling in the remaining 23 families. All
the families gave informed consents for interview,
DNA and cell line storage at Rutgers University Cell
and DNA repository (Piscataway, NJ, USA) and
sharing of anonymous clinical and genotype data at
the National Institute of Mental Health central
depository. Ethical approval for the study was
obtained from National Institute of Health registered
ethical review boards from each center.
Genotyping and data cleaning
The genotyping service was provided by the Center
for Inherited Disease Research (http://www.cidr.jh
mi.edu/) using the Illumina BeadArray technology on
a BeadLab system. A total of 5873 SNPs from the
Illumina Linkage IVB SNP panel were successfully
assayed with a reproduction rate of 99.994%. The
markers were ordered and placed on the physical map
according to Genome Build 35. Interpolated genetic
distances from the deCODE genetic map were used to
estimate genetic map distances.20
Pedigree errors were identified and corrected by
testing pairwise subject relationships with the pro-
gram Relpair.21 Genotypes causing Mendelian inconsis-
tencies were identified by Pedcheck and removed by
a custom script.22 Hardy–Weinberg equilibrium
(HWE) for each marker was calculated using Pedstats
and 138 SNP markers with significant departure from
HWE (Pp0.01) were dropped from the analysis.23
Unlikely genotype combinations leading to double
recombinations over short genetic distance in a few
cases were removed by Merlin.24
Linkage analysis
Nonparametric linkage was examined by Merlin using
Whittemore and Halpern’s Sall statistics and Kong and
Cox’s log of the odds (LOD) score transformation.24–26
Linkage disequilibrium has been shown between
tightly linked markers on the Illumina Linkage IV
SNP panels14 and treating them as independent
markers can inflate LOD scores.27 Merlin overcomes
this problem by clustering markers that are in LD and
estimating the haplotype frequencies to perform
multipoint linkage analysis with the composite
markers.28 We implemented the ‘rsq 0.05’ constraint
which requires a pairwise LD measure of r2 < 0.05
between adjacent markers to create marker clusters; as
suggested by a comprehensive simulation study.29
Results
Figure 1 illustrates the nonparametric linkage multi-
point LOD scores on the autosomes and the
X chromosome. Table 2 lists the genomic regions
showing at least nominal linkage signals (multipoint
LOD > 1.0) and the markers associated with the
peak scores. Nominal linkage signals were found
on chromosome 2, 11, 14, 21 and the X chromo-
some. There are two suggestive linkage signals with
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multipoint LOD scores exceeding 2.0 on chromosome
9 (LOD = 2.13; P = 0.0009) and chromosome 16
(LOD = 3.1; P = 0.00008). Detailed linkage signal pro-
files at these two regions are shown in Figure 2.
Since the IMAGE project is a multi-country
cooperative project, the presence of genetic hetero-
geneity is a potential concern for molecular genetic
studies. If there is locus-specific genetic heterogeneity
where the allele frequencies of the linked locus are
significantly different between countries, it might be
advantageous to test for linkage with a stratified
sample based on a priori knowledge.30 Given that
we found a certain level of background genetic
heterogeneity in the IMAGE sample which was
reflected by significant allele frequency differences
between the Israeli samples and the rest of the IMAGE
samples in our previous investigation of 51
ADHD candidate genes,13 we repeated the same
nonparametric linkage analysis without the 18 Israeli
families. As shown in Table 2, the suggestive linkage
peak on chromosome 16 increased above the
provisional criteria of significant linkage while the
peak on chromosome 9 decreased. To examine
whether the newly derived LOD scores were
statistically different from the original findings, we
repeated the nonparametric linkage analysis 10 000
times by randomly dropping 18 families each time.
For the chromosome 9 finding, a LOD score less
than 1.43 occurred 1561 times, suggesting that the
contribution of the Israeli families to this linkage peak
was not significantly different from the others. For
chromosome 16, a LOD score above 3.82 occurred on
Table 1 Clinical features of the IMAGE sample and comparison with other ADHD-affected sibling pair linkage scans
Study IMAGE UCLA Germany Netherlands
Number of affected siblings 276 438 229 199
Male (%) 78.6 71.9 72.1 83.9
White Caucasian (%) 100 80 100 100
ADHD Subtype N (%) N (%) N (%) N (%)
Combined 276 100 211 48 158 69 170 85
inattentive 0 0 196 45 61 27 25 13
Hyperactive-impulsive 0 0 31 7 10 4 4 2
Comorbid disorder
Oppositional defiant disorder 156 57 239 55 55 24 82 41
Conduct disorder 72 26 64 15 8 3 14 7
Mood disorder 41 15 97 22 4 2 15 8
Anxiety disorder 96 35 45 10 18 8 27 14
Age and IQ Mean S.d. Mean S.d. Mean S.d. Mean S.d.
Age 10.6 3.1 11.1 3.6 11.1 — 10 3
IQ 98.3 14.5 105.9 14.2 102.4 — > 80 —
Abbreviations: ADHD, attention deficit hyperactivity disorder; IMAGE, International Multi-centre ADHD Genetics; IQ,
intelligence quotient; UCLA, University of California, Los Angeles.
Figure 1 Genome-wide multipoint nonparametric log of the odds (LOD) scores for combined subtype attention deficit
hyperactivity disorder (ADHD).
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348 occasions, suggesting that the contribution of the
Israeli families to this linkage peak was significantly
lower than the others.
Discussion
In this study we performed a whole-genome linkage
scan with 142 combined subtype ADHD sib pairs. By
using a state-of-the-art SNP linkage panel, we were
able to extract more than 95% of the information
content for linkage throughout the genome. Sugges-
tive linkage was found on chromosomes 9 and 16
along with the other nominal linkage signals. Table 3
lists all the linkage evidence observed in the current
study and a detailed comparison with the other
ADHD linkage scans. To make more accurate compari-
sons, all the genetic map positions reported in
previous studies were transformed into deCODE
map position.20
Our highest linkage signal of LOD = 3.1 was found
on chromosome 16q23. The multipoint nonpara-
metric LOD peaks at 99 cM on the deCODE genetic
map in the vicinity of SNP rs424074. It appears to be
an entirely different peak from that reported by the
UCLA study on chromosome 16p13 at position
34.5 cM on the deCODE map with a LOD score of
3.73.8 However, both the UCLA sample and the
narrow phenotype analysis of the Dutch sample10
gave nominal linkage signals on 16q (1.0 < MLS < 1.5,
no details reported) at positions around 95 and
100 cM, respectively. Both of them fall within the
LOD-1 interval of the main peak observed in the
current study. Furthermore, when the raw data from
the UCLA and Dutch samples were pooled in a
combined analysis, a slightly higher maximum LOD
score (MLS) was obtained in the same genomic region
(1.5 < MLS < 2.0).31
Alongside our main peak there is another weaker
linkage peak on chromosome 16q12 with multipoint
Table 2 Chromosome regions with nonparametric multipoint LOD > 1.0
Chromosome Marker Physical position Genetic distancea LOD No. of markersb S-LODc
2 rs1510834 13694789 34.5 1.64 8 (7.9) —
2 rs2033866 174914536 181.5 1.16 3 (0.7) —
9 rs7043803 88533215 90 2.13 9 (10.2) 1.43
11 rs630759 62933285 69 1.31 6 (2.1) —
14 rs1361525 94339381 100 1.75 15 (8) —
16 rs837529 54043795 70.7 1.51 5 (3.2) —
16 rs424074 77792088 99 3.10 34 (29.6) 3.82
21 rs875060 42817300 61.4 1.53 11 (7.8) —
X rs728186 137867027 141.9 1.25 4 (2.6) —
Abbreviation: LOD, log of the odds.
adeCODE genetic map positions.
bNumber of consecutive SNP markers at the peak with multipoint LOD > 1.0 and (in brackets) the genetic distance they
spanned in cM.
cMultipoint LOD scores calculated in a stratified sample without the 18 Israeli families. Analysis was restricted to the two
suggestive linkage peaks.
Figure 2 Nonparametric multipoint log of the odds (LOD) scores on chromosomes 9 and 16. Nonparametric multipoint LOD
scores on chromosomes 9 and 16 in full sample (blue lines) and stratified sample without 18 Israeli families (red lines). The
dash lines are provisional criteria for suggestive (LOD = 2.2) and significant linkage (LOD = 3.6) suggested by Lander and
Kruglyak.
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LOD = 1.51 at 70.7 cM. Although the linkage signal in
this region is only nominal, it is worth noting that the
noradrenergic neurotransmitter transporter gene
(SLC6A2/NET1) located at position 75.5 cM. SLC6A2
has been reported to show association with ADHD in
several studies and warrants further investiga-
tion.1,32,33
We found the second suggestive linkage peak of
LOD = 2.13 on chromosome 9q22 at position 90 cM.
Both the UCLA and the German studies found some
linkage evidence at almost the same location with LOD
scores of 1.45 and 0.68, respectively. Although the
Dutch study also found suggestive linkage (MLS = 2.05)
at the adjacent 9q33 region, the peak position was at
132.9 cM with no overlap of confidence intervals with
the linkage signal found in this study.
It is encouraging that both loci identified in our
study showed overlap with linkage signals from
previous studies. This indicates an increased possi-
bility that one or more genes located in these two
regions make a real contribution to the risk for ADHD.
Assuming that the two main peaks on chromosomes
16 and 9 are true linked loci, we estimate that they
each contribute a genotypic sibling risk (ls) of 1.65
and 1.89, respectively to the overall familial risk of
ADHD (ls = 1/4z0, where z0 is the estimation of sharing
0 allele at the locus).34
As shown in Table 3, we were unable to identify
any other significant overlap of linkage peaks with the
three published affected sibling pair studies and none
with the study of Columbian multiplex families. The
MGH scan found no significant evidence for linkage
across the genome in an affected sibling pair analysis
on 217 families (Faraone et al., submitted). Further-
more, no linkage was observed in our study at the
most established ADHD-linked genomic regions of 5p
and 17p; indeed neither of these two loci was
consistently found in previous scans and most other
observations were single hits. Overall, there is a
general lack of consistency across all the ADHD
linkage scans as found in many other psychiatric
and common complex disorders. Furthermore, these
data suggest that there are unlikely to be genes of
moderate to large effect shared across the various
populations studied.
One obvious reason for the observed pattern of
findings is the complex genetic etiology of ADHD,
which likely involves the combination of multiple
small additive and interaction effects.6 The presence
of significant clinical and demographical diversity in
the studied samples is another potential reason.
Factors that might increase heterogeneity between
the studies include differences in the populations
sampled, although the German and Dutch samples are
from closely related northern European populations
and the UCLA and MGH samples largely consist of
families of European ancestry (B80%). The clinical
sample studied here, consisting of 100% combined
type cases, is more closely comparable to the Dutch
(85%) and the German (69%) than the UCLA (48%)
samples; yet both of the top two loci overlap with data
from UCLA. It is feasible that our more homogeneous
sample of combined type probands might have led to
the relatively high LOD scores for these two loci.
However, the polygenic nature of ADHD genetics and
the stochastic fluctuations originating from modest
sample size can be expected to show a certain level of
fluctuation of true linkage signals.35
A major design feature of the current study is that
the analysis was restricted to the DSM-IV combined
subtype ADHD diagnosis to reduce the potential
genetic heterogeneity caused by clinical heterogene-
ity. It has been suggested that there may be some
difference in the genetic influences acting on the
DSM-IV subtypes of ADHD.36–38 The DSM-IV com-
bined subtype of ADHD has been shown to fall
entirely within an empirically derived latent class
with a high level of subtype concordance within twin
pairs.39,40 The combined subtype is also the most
common presentation of ADHD within child and
adolescent psychiatric clinics and is associated with
high levels of hyperactive-impulsive, inattentive and
comorbid problems.36 Furthermore, since the whole
IMAGE sample were ascertained through DSM-IV
combined subtype ADHD probands, there were not as
many inattentive or hyperactive subtype children in
Table 3 Comparison of the main findings emerged in this study with previous studies
Chromosome IMAGE LOD UCLA MLS Netherlands MLS Germany LOD
Location Location Location Location
2 34.5 1.64 — — — — — —
2 181.5 1.16 171 1.00a — — — —
9 90 2.13 93 1.45 132.9 2.05 99.7 0.68
11 69 1.31 72.1 1.17a — — — —
14 100 1.75 — — — — — —
16 70.7 1.51 — — — — — —
16 99 3.1 E90 cM > 1.0 E100 cM > 1.0 — —
21 61.4 1.53 — — — — — —
X 141.9 1.25 — — — — — —
Abbreviations: IMAGE, International Multi-centre ADHD Genetics; MLS, maximum LOD score; UCLA, University of
California, Los Angeles.
aSingle-point LOD score.
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the IMAGE sample as in the other nonselected ADHD
samples. Therefore, we opted to apply the more
stringent diagnosis to achieve more genetic homo-
geneity in our main report rather than a bigger sample
with more confounding possibilities.
To avoid the loss of power associated with multiple
testing of different phenotypic definitions, we
decided a priori to restrict the main test of linkage
to the analysis of combined subtype samples alone. To
allow for comparison with the previous linkage scans
that combined all three of the ADHD subtypes, we
repeated the nonparametric linkage analysis with a
relaxed criteria to include all ADHD cases, regardless
of subtype. In this extended analysis there were 227
families containing the equivalent of 246 affected
sibling pairs. As shown in the online Supplementary
Figure 1, there is no suggestive linkage signal across
the genome and both suggestive linkage signals at
chromosomes 9 and 16 are diminished compared to
the main report. While it is feasible that our more
homogeneous sample might have led to the relatively
high LOD scores at these two loci, stochastic fluctua-
tions could also lead to the pattern of observations
accrued so far.
One potential concern is that locus-specific genetic
heterogeneity within the IMAGE multi-site dataset
could hinder the linkage test results. For example, the
low frequency of a genetic risk factor in one of the
subpopulations studied would reduce the overall
effect size across the combined dataset, resulting in
a loss of power. Based on our previous investigation,
we decided to specifically reanalyze the two sugges-
tive linkage loci in a stratified sample without the 18
Israeli families.13 Interestingly, the linkage signal on
chromosome 16 increased and passed the provisional
significance criteria for linkage, with a LOD score of
3.82. Our further simulations demonstrated that this
increase was statistically significant (P = 0.035). This
result showed that the linkage evidence could be
enhanced when sample stratification was taken into
account based on prior knowledge. However, because
our full sample size is small and the numbers of
families from individual countries are even smaller,
random sampling bias could also account for the level
of observed genetic heterogeneity.
To explore this possibility, we went on to check
more systematically for the effect of dropping families
from other recruiting sites, and did indeed find
additional evidence of heterogeneity from other sites
(Supplementary Table 1). However, since we per-
formed several such tests we completed a further
simulation of 10 000 datasets in which we dropped
samples representing the proportions of each of the
six-country groups, to generate an empirical distribu-
tion of 60 000 (610 000) simulated LOD scores. The
overall levels of significance adjusted for each of the
heterogeneity tests were no longer significant, indi-
cating no overall significant evidence of heterogene-
ity. The results suggested that stratification of samples
is unlikely to improve the chance to detect a real
linkage signal due to the problem of multiple testing.
Nevertheless, testing for heterogeneity might be a
useful approach where there is prior evidence of
genetic heterogeneity. In this study we cannot clearly
establish whether the population mixture in this
sample has compromised the power of the analysis
until we have identified specific alleles that account
for the linkage signals identified.
In summary, we have identified two suggestive
ADHD linkage regions on chromosomes 9 and 16,
respectively. It is encouraging that both loci over-
lapped with some evidence of linkage in previous
ADHD linkage scans, however the current study and
the previous scans all used relatively small sample
sizes that do not provide sufficient statistical power to
consistently detect linkage to loci conferring rela-
tively small genetic risks. As shown in a recent
combined study of two previous linkage scans of
ADHD, meta-analysis and reanalysis of the combined
raw data provided not only enhanced linkage signals,
but also evidence of genetic heterogeneity at chromo-
some 5p.31 Thus, a meta-analysis of all available
linkage data is now warranted. Although whole-
genome association is theoretically a more powerful
method to detect common ADHD genes, an important
obstacle toward interpretation of such data is the
multiple test correction.41,42 Applying the prior
knowledge of genomic linkage may help to prioritize
specific regions with lower multiple test correction
penalties. Linkage approaches can also be useful for
gene mapping if the ‘common disease multiple rare
allele’ scenario, where multiple causal alleles exist
within genes, holds true.
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